Libby's H*O*P*E*

*Helping*Ovarian Cancer Survivors*Persevere Through*Education

Menu

Skip to content
  • Home
  • About
  • Mission
  • Warning Signs & Symptoms
  • Ovarian Cancer Overview
  • Prevention, Early Detection/Screening & Causes
  • Genetics
  • Types of Ovarian Cancer
  • Diagnosis & Staging
  • Treatment Overview
  • Surgery
  • Chemotherapy
  • Radiology & Radiation Therapy
  • Hormonal (Anti-Estrogen) Therapy
  • Biological (Immunotherapy & Vaccine) Therapy
  • Gene Therapy
  • Alternative & Complementary Therapy
  • Clinical Development
  • Clinical Trials
  • Coping
  • Survivorship
  • Ovarian Cancer Resources
  • Contact

Tag Archives: Univ. of Washington

Symptoms Of Ovarian Cancer Remain Relatively Stabile Over Time As Reported By High Risk Women

Posted on May 17, 2009 by Paul Cacciatore

Researchers from the Fred Hutchinson Cancer Research Center reported recently that symptoms of ovarian cancer tend to be relatively stable over time for women who are at increased risk of ovarian cancer based upon family history of cancer or BRCA 1/2 gene mutation.

Continue reading →

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Reddit (Opens in new window) Reddit
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email
Like Loading...
Posted in Medical Study Results, Symptoms | Tagged American Cancer Society, Barbara A. Goff M.D., BRCA gene mutations, BRCA1, BRCA2, early warning signs & symptoms, Fred Hutchinson Cancer Research Institute, Gynecologic Cancer Foundation, ovarian cancer, Ovarian Cancer Early Detection Study, Society of Gynecologic Oncologists, Symptoms Index, Univ. of Washington | Leave a comment
"Once you choose hope, anything is possible." -- Christopher Reeve

Categories

RSS Google Ovarian Cancer News

  • Lipid-Protein Biomarker Makes Clinical Debut with Early Ovarian Cancer Detection - Inside Precision Medicine
  • Ovarian cancer drug approved for NHS use will prolong lives - The Conversation
  • Novel nanowire device offers rapid, noninvasive cancer detection - Phys.org
  • Compugen to present ovarian cancer trial poster at ESMO - Investing.com
  • Dr Mathews on Updated Data From the RAINFOL-01 Trial in Advanced Ovarian Cancer - OncLive
  • Appeals Court Affirms Retrial Over J&J Baby Powder Cervical Cancer - Mesothelioma.net
  • AI-driven cancer firm to present ovarian trial at ESMO 2026 - Stock Titan
  • From memory to medicine: A son’s journey toward a cure - Newsroom | UCLA
  • New targeted therapies aim to deliver chemotherapy more precisely for ovarian cancer - UCLA Health
  • Breakthrough ovarian cancer drug offers patients more time and better quality of life - BBC

Top Posts

  • About
    About
  • Federal Enactment of the 2008 Genetic Information Nondiscrimination Act (GINA) As Law Appears Imminent
    Federal Enactment of the 2008 Genetic Information Nondiscrimination Act (GINA) As Law Appears Imminent
  • Working Smarter, Not Harder: Use of Anti-Estrogen Therapy to Battle Recurrent Ovarian Cancer
    Working Smarter, Not Harder: Use of Anti-Estrogen Therapy to Battle Recurrent Ovarian Cancer
  • Massachusetts General Hospital Cancer Center To Genetically Profile All Patient Tumors
    Massachusetts General Hospital Cancer Center To Genetically Profile All Patient Tumors
  • 2011 ASCO: Exelixis Reports Expanded Cabozantinib (XL184) Phase II Data For Advanced Ovarian Cancer; Six Deaths Reported
    2011 ASCO: Exelixis Reports Expanded Cabozantinib (XL184) Phase II Data For Advanced Ovarian Cancer; Six Deaths Reported
  • Proposed Federal Gov't Rule Adds Ovarian Cancer to 9/11 World Trade Center Health Program List of Covered Conditions
    Proposed Federal Gov't Rule Adds Ovarian Cancer to 9/11 World Trade Center Health Program List of Covered Conditions
  • Non-Platinum Topotecan Drug Combination Therapy Provides No Survival Advantage Over Topotecan Monotherapy
    Non-Platinum Topotecan Drug Combination Therapy Provides No Survival Advantage Over Topotecan Monotherapy
  • Meet Laurey Masterton, 20-Year Ovarian Cancer Survivor Extraordinaire
    Meet Laurey Masterton, 20-Year Ovarian Cancer Survivor Extraordinaire
  • 2009-2010 U.S. News & World Report Best U.S. Hospital Rankings
    2009-2010 U.S. News & World Report Best U.S. Hospital Rankings

Archives

  • May 2015
  • September 2014
  • August 2014
  • May 2014
  • March 2014
  • August 2013
  • May 2013
  • February 2013
  • January 2013
  • July 2012
  • June 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008

Blog Stats

  • 509,272 Visitors
cancer blog

Enter your email address to subscribe to Libby's H*O*P*E* & receive notifications of new posts by email.

Join 342 other subscribers

 Subscribe in a reader

Click on the orange button above if you want to (i) add Libby's H*O*P*E*(tm) updates to a web-based or other reader, or (ii) embed a Libby's H*O*P*E* (tm) update widget on your desktop, website or blog.

Donate To Ovarian Cancer Research

OCRF is the largest U.S. private funding agency supporting ovarian cancer research. It is a not-for-profit, 501(c)(3) organization. Click on the OCRF logo above to make a donation.

Strategic Partners

Podcasts

Join Us In the Fight Against Ovarian Cancer

RSS New Ovarian Cancer Clinical Trials (Past 14 Days)

  • Safety of Opportunistic Salpingectomy During Elective Laparoscopic Cholecystectomy.
  • Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer
  • 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors
  • Prehabilitation in High-risk Oncologic Surgery
  • The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
  • An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy
  • Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
  • Preventing Ovarian Cancer Through Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy
  • A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors
  • Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2

RSS New Adult Solid Tumor Clinical Trials (Past 14 Days)

  • Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC
  • Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial
  • A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets
  • A Study of MSK-TCR5 in People With Solid Tumor Cancers
  • Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy
  • 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors
  • Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC
  • N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors
  • An Initial Evaluation of AN8025 in Solid Tumors
  • Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors

RSS Medical Studies

  • Deciphering the Pleiotropic Role of ARID1a and RIF1 in Endometrioid Ovarian Cancer
  • Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Prophylactic Mastectomy & Breast Reconstruction: A Case Report
  • Editorial: Endometrial health and disease: from molecular insights to clinical advances
  • Assessment of right ventricular systolic function via the AutoStrain Right Ventricle technique in patients with ovarian cancer during early-stage chemotherapy
  • Value of an (18)F-FDG-based peritoneal cancer index in predicting dualistic classification, tumor burden, and completeness of cytoreductive surgery in epithelial ovarian cancer
  • Bioinspired oxidized mRNA lipid nanoparticles for ex vivo engineering of chimeric antigen receptor macrophages targeting solid tumors
  • Malignant Small Bowel Obstruction Unveiling Rare High-Grade Serous Ovarian Carcinoma of Mullerian Origin: A Case Report Detailing Diagnosis and Management
  • Genetic variants in the homologous recombination pathway as common risk for premature ovarian insufficiency and ovarian cancer
  • Mid-infrared photothermal relaxation intensity diffraction tomography for video-rate volumetric chemical imaging
  • Predictors of postoperative morbidity and delayed initiation of adjuvant chemotherapy after cytoreductive surgery in advanced-stage epithelial ovarian cancer

Recent Comments

Prometey Bank's avatarPrometey Bank on World Ovarian Cancer Day: Toge…
mikaljhohnashly's avatarmikaljhohnashly on World Ovarian Cancer Day: Toge…
Jan C. Calthrop's avatarJan C. Calthrop on Lab-On-A-Chip: Veridex & M…
Paul Cacciatore's avatarPaul Cacciatore on About
Building a Team for… on About
Kathleen's avatarKathleen on About
Paul Cacciatore's avatarPaul Cacciatore on About
Liz's avatarLiz on About
Paul Cacciatore's avatarPaul Cacciatore on Dana Farber Webchat: The Lates…
Judith Marengere's avatarJudith Marengere on Dana Farber Webchat: The Lates…
Paul Cacciatore's avatarPaul Cacciatore on Dana Farber Webchat: The Lates…
Franca Pichini's avatarFranca Pichini on Dana Farber Webchat: The Lates…
painspeaks's avatarpainspeaks on SU2C Announces the Formation o…
marcy westerling's avatarmarcy westerling on SU2C Announces the Formation o…
anne's avataranne on Dana-Farber Oncologists Differ…

Blogroll

  • Site Meter Site Meter

Cancer Organizations

  • American Cancer Society
  • National Cancer Institute

Everyday Heroes

  • Are You There Cancer? It's Me, Jennie.
  • Bald Heads Are Sexy
  • Butterfly Ballet
  • Cancer Queen
  • Carrie's Journey
  • Chris Bledy
  • Diary of a Cancer Patient
  • I Want To Breathe
  • Janine's News
  • Journey Through Ovarian Cancer
  • Kristi & Brian: Living! With Cancer
  • Laurey Bikes
  • Life Cycle
  • livingly dying
  • Marcheline Bertrand Remembered
  • Meghan's Message
  • Monday Hearts For Madalene
  • My Journey With Teal
  • Nobody Has Ovarian Cancer
  • Out Shine Ovarian Cancer
  • OVACOM
  • Ovarian Cancer News
  • Ovarian Cancer?? pass the wine … now!
  • Scrambled Eggs, Surviving Ovarian Cancer
  • Shannon Miller Lifestyle
  • Still Smiling
  • Strong As Steele
  • Tenaciously Teal
  • The Carcinista
  • What? Me Worry?
  • Will There Be Cows In Heaven?
  • Women of Teal

Inspirational Cancer Advocates

  • Bald Is Beautiful
  • Bicycling For Ovarian Cancer (Craig Broeder)
  • Christine Druther
  • Fran Drescher
  • Imerman Angels
  • Jenn Sommermann: Training For a Cure
  • Jim Valvano
  • Laurey Masterton
  • Maddie Kullen
  • Mothers With Cancer
  • Randy Pausch
  • Sean Swarner
  • Standup2cancer
  • The Rock Band N.E.D.

Ovarian Cancer News Archive

  • Ovarian Cancer News Archive

Ovarian Cancer Organizations

  • National Breast & Ovarian Cancer Connection
  • National Ovarian Cancer Coalition
  • Ovarian Cancer National Alliance
  • Ovarian Cancer Research Fund
  • Ovations For the Cure

U.S. Treatment Centers

  • National Comprehensive Cancer Network Member Institutions
  • NCI-Designated Cancer Centers

Video Archive

  • Ovarian Cancer Video Library
Copyright 2008 - 2016 Paul Cacciatore, Libby's H*O*P*E*(TM), *Helping *Ovarian Cancer Survivors *Persevere Through *Education(TM), all rights reserved.
Paul Cacciatore

Create Your Badge
Site Meter
Blog at WordPress.com.
  • Subscribe Subscribed
    • Libby's H*O*P*E*
    • Join 217 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Libby's H*O*P*E*
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
%d